These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 38674702)

  • 21. Acanthamoeba keratitis: 10-year study at a tertiary eye care center in Hong Kong.
    Chin J; Young AL; Hui M; Jhanji V
    Cont Lens Anterior Eye; 2015 Apr; 38(2):99-103. PubMed ID: 25496910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acanthamoeba Keratitis Risk Factors for Daily Wear Contact Lens Users: A Case-Control Study.
    Carnt N; Minassian DC; Dart JKG
    Ophthalmology; 2023 Jan; 130(1):48-55. PubMed ID: 35952937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acanthamoeba keratitis: An emerging disease among microbial keratitis in the Cap Bon region of Tunisia.
    Zbiba W; Abdesslem NB
    Exp Parasitol; 2018 Sep; 192():42-45. PubMed ID: 29859227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the management of Acanthamoeba keratitis: A review of the literature and synthesized algorithmic approach.
    Kaufman AR; Tu EY
    Ocul Surf; 2022 Jul; 25():26-36. PubMed ID: 35462076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of domestic tap water on Acanthamoeba keratitis in non-contact lens wearers and validation of laboratory methods.
    Koltas IS; Eroglu F; Erdem E; Yagmur M; Tanır F
    Parasitol Res; 2015 Sep; 114(9):3283-9. PubMed ID: 26017346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review.
    Carnt N; Stapleton F
    Ophthalmic Physiol Opt; 2016 Mar; 36(2):77-92. PubMed ID: 26691018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Confocal Microscopy for the Diagnosis of Polymerase Chain Reaction-Positive Acanthamoeba Keratitis: A Case-Control Study.
    De Craene S; Knoeri J; Georgeon C; Kestelyn P; Borderie VM
    Ophthalmology; 2018 Feb; 125(2):161-168. PubMed ID: 28965660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotyping of Acanthamoeba isolates and clinical characteristics of patients with Acanthamoeba keratitis in China.
    Zhao G; Sun S; Zhao J; Xie L
    J Med Microbiol; 2010 Apr; 59(Pt 4):462-466. PubMed ID: 20056772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Rabbit Model of Acanthamoeba Keratitis That Better Reflects the Natural Human Infection.
    Feng X; Zheng W; Wang Y; Zhao D; Jiang X; Lv S
    Anat Rec (Hoboken); 2015 Aug; 298(8):1509-17. PubMed ID: 25766300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical experience of Acanthamoeba keratitis at a tertiary care eye hospital.
    Tanhehco T; Colby K
    Cornea; 2010 Sep; 29(9):1005-10. PubMed ID: 20539211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acanthamoeba in the eye, can the parasite hide even more? Latest developments on the disease.
    Juárez MM; Tártara LI; Cid AG; Real JP; Bermúdez JM; Rajal VB; Palma SD
    Cont Lens Anterior Eye; 2018 Jun; 41(3):245-251. PubMed ID: 29273391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the Diagnostic Potential of Chorismate Mutase Poly-Clonal Peptide Antibody for the
    Kim MJ; Jo HJ; Sohn HJ; Shin HJ; Quan FS; Kong HH; Moon EK
    Pathogens; 2023 Mar; 12(4):. PubMed ID: 37111412
    [No Abstract]   [Full Text] [Related]  

  • 33. Acanthamoeba keratitis and contact lens wear.
    Lindsay RG; Watters G; Johnson R; Ormonde SE; Snibson GR
    Clin Exp Optom; 2007 Sep; 90(5):351-60. PubMed ID: 17697181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acanthamoeba keratitis challenges a case report.
    Cristina S; Cristina V; Mihaela P
    Rom J Ophthalmol; 2016; 60(1):40-2. PubMed ID: 27220232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acanthamoeba keratitis: A 4-year review from a tertiary care hospital in North India.
    Megha K; Thakur A; Khurana S; Sehgal R; Gupta A
    Nepal J Ophthalmol; 2020 Jan; 12(23):83-90. PubMed ID: 32799243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors, management, and outcomes of
    Scruggs BA; Quist TS; Zimmerman MB; Salinas JL; Greiner MA
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101372. PubMed ID: 35198803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acanthamoeba genotypes T3 and T4 as causative agents of amoebic keratitis in Mexico.
    Omaña-Molina M; Vanzzini-Zago V; Hernandez-Martinez D; Gonzalez-Robles A; Salazar-Villatoro L; Ramirez-Flores E; Oregon-Miranda E; Lorenzo-Morales J; Martinez-Palomo A
    Parasitol Res; 2016 Feb; 115(2):873-8. PubMed ID: 26581373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of
    Kim MJ; Ham AJ; Park AY; Sohn HJ; Shin HJ; Quan FS; Kong HH; Moon EK
    Microorganisms; 2022 Aug; 10(9):. PubMed ID: 36144313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acanthamoeba Keratitis in Egypt: Characteristics and Treatment Outcomes.
    Nasef MH; El Emam SY; ElShorbagy MS; Allam WA
    Clin Ophthalmol; 2021; 15():1339-1347. PubMed ID: 33824578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability.
    Chomicz L; Conn DB; Padzik M; Szaflik JP; Walochnik J; Zawadzki PJ; Pawłowski W; Dybicz M
    Biomed Res Int; 2015; 2015():231285. PubMed ID: 26682216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.